MedTrace Logo

Brain Stimulation for Concussion

NCT05889117 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2025-09-30

No results posted yet for this study

Summary

The goal of this clinical trial is to test a new type of magnetic brain stimulation in patients with persistent post-concussive symptoms. Participants will undergo detailed MRI scans before and after 30 treatment sessions (of 3-10 minutes each). The main questions the study aims to answer are:

* Will this new type of treatment result in fewer symptoms and better daily functioning?
* What are the effects of this treatment on brain functioning?

Conditions

  • Transcranial Magnetic Stimulation
  • Magnetic Resonance Imaging
  • Neuropsychological Tests
  • Traumatic Brain Injury
  • Post-Concussion Syndrome

Interventions

DEVICE

Intermittent theta-burst treatment (iTBS) using MagPro Transcranial Magnetic Stimulator (manufacturer: Magventure)

3-10 minute sessions of brain stimulation applied to the left dorsolateral prefrontal cortex, up to 10 sessions a day, 30 sessions in total, planned within 2 weeks.

Sponsors & Collaborators

  • University of New Mexico

    collaborator OTHER

  • The Mind Research Network

    lead OTHER

Principal Investigators

  • Harm J van der Horn, MD PhD · Mind Research Network

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-30
Primary Completion
2025-04-01
Completion
2026-05-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05889117 on ClinicalTrials.gov